This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

APO-Verap SR (2015-05-19)

Starting date:
May 19, 2015
Posting date:
May 21, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-53499

Recalled products

  1. APO-Verap SR 180 mg

Reason

Out of Specification result for dissolution testing.

Depth of distribution

Wholesalers

Affected products

A. APO-Verap SR 180 mg

DIN, NPN, DIN-HIM
DIN 02246894
Dosage form

Tablet (Extended-Release)

Strength
  • Verapamil hydrochloride 180 mg
Lot or serial number
  • MC 9090
Companies
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA

Apotex Product Recall (2015-04-10)

2015-04-10 | Health products

Recall

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: